Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Muenchensteinerstrasse 38, Basel, , CH-4002, CH
Lonza is one of the world’s largest CDMOs dedicated to serving the healthcare industry. Working across five continents, our global team of more than 19,000 colleagues works alongside pharma and biotech companies to turn their breakthrough innovations into viable therapies. We support our customers in bringing life-saving and life-enhancing treatments to patients worldwide with a combination of cutting-edge science, smart technology and lean manufacturing.
This white paper delivers an analysis of critical success factors for effective technology transfer.
Released By Lonza
As a leader of technology transfer activities in the industry, Lonza understands the challenges associated with this critical step.
Discover how this scalable and robust technology can facilitate the development and manufacturing of your bioconjugate drug.
Learn more about the scale up of antibody drug conjugates payloads by viewing this webinar.
Lonza's Michiya Hayakawa provides an overview of the current market and presents strategies for manufacturing highly potent active drugs.
Selection of the proper technology can make the difference between development success or failure. Learn more in this whitepaper from Lonza Pharma & Biotech.
Aims to position itself as a leading pan-European independent biologics CDMO.
By: Charlie Sternberg
To extend Coriolis’ position in formulation development and analytical services for innovative high-value biologics, cell and gene therapy products.
By: Anthony Vecchione
A Q&A with Dan Dobry, head of drug product commercial development at Lonza Pharma & Biotech.
By: Tim Wright
Oral solids remain the preferred route of drug delivery due to their cost-effectiveness, ease of manufacturing, and patient-friendly dose form options.
Lonza’s Director of Commercial Development, Sean Diver, was recently named President of DCAT.
Karen will work to further expand the company's contract manufacturing business, which delivers GMP materials to third parties developing COVID-19 vaccines.
By: Contract Pharma
Can now provide capsule-based DPI formulations for feasibility studies in as little as 12 weeks.
Cell and gene therapies represent the new wave of innovation in the life sciences industry
Managing accelerated timelines in manufacturing high-potency drugs.
By: Maurits Janssen
Yan Wang to step down as Cytovance’s interim chief executive
Members include Magda Marquet, Jim Miller, Bob Kanuga and Joseph Colleluori.
By: Kristin Brooks
Ongoing collaboration and tech transfers started in 2018 for the clinical manufacturing of LAD-I.
Lonza’s manufacturing site in Houston, TX will handle all product supply for DiNA-001.
Sign agreement to use Lonza’s GS Gene Expression System for Navrogen’s anti-HIO targeting agents.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
